A potent malaria transmission blocking vaccine based on codon harmonized full length Pfs48/45 expressed in Escherichia coli.
Malaria caused by Plasmodium falciparum is responsible for nearly 1 million deaths annually. Although much progress has been made in the recent past, the development of a safe, effective and affordable malaria vaccine has remained a challenge. A vaccine targeting sexual stages of the parasite will n...
Main Authors: | Debabani Roy Chowdhury, Evelina Angov, Thomas Kariuki, Nirbhay Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-07-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2709910?pdf=render |
Similar Items
-
Structural delineation of potent transmission-blocking epitope I on malaria antigen Pfs48/45
by: Prasun Kundu, et al.
Published: (2018-10-01) -
A Plant-Produced in vivo deglycosylated full-length Pfs48/45 as a Transmission-Blocking Vaccine Candidate against malaria
by: Tarlan Mamedov, et al.
Published: (2019-07-01) -
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody
by: Frank Lennartz, et al.
Published: (2018-09-01) -
Transmission blocking immunity as observed in a feeder system and serological reactivity to Pfs 48/45 and Pfs230 in field sera
by: W. Roeffen, et al.
Published: (1994-01-01) -
Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum
by: Susheel K. Singh, et al.
Published: (2019-06-01)